BREAST CANCER BASE

Female breast cancer is the most common malignancy in the world context, the incidence of breast cancer is rising year on year. Epidemiological data show that the United States breast cancer mortality rate has been going down, with the strengthening of the census, the rise of early breast cancer detection rate and systemic adjuvant therapy is still unknown.

More than 40 years ago, Fisher raised breast cancer is a systemic disease. Studies show about 1% to 5% of breast cancer patients receiving treatment has been found that when the metastatic lesions. Early breast cancer might have systemic micrometastases, most patients are in need of systemic medical treatment. The current treatment model has been widely accepted-conserving surgery and adjuvant treatment system has been extensively used in early breast cancer.

Chemotherapy is the role of cytotoxic drug eradication Yat into the bloodstream and lymphatic system cancer, when the transfer occurred and relapse, the drug is the main treatment.

Chemotherapy is a systemic treatment, the relative efficacy of tumor spread from the restrictions, but by <BR> cancer load restrictions, and radiotherapy, surgery and other treatment methods, and help to increase the cure rate of breast cancer. The efficacy of the performance are as follows.

(1) chemotherapy for breast cancer micrometastases of treatment compared to the large metastases effective.